EDESA BIOTECH, INC. Other Cost of Operating Revenue
EDESA BIOTECH, INC. (EDSA) reported Other Cost of Operating Revenue of $35.41 thousand for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherCostOfOperatingRevenue · last filed 2019-05-08
- EDESA BIOTECH, INC. other cost of operating revenue for the quarter ending 2019-03-31 was $35.41K, a 52.42% decline year-over-year.
- EDESA BIOTECH, INC. other cost of operating revenue for the quarter ending 2018-12-31 was $78.28K, a 20.16% decline year-over-year.
- EDESA BIOTECH, INC. other cost of operating revenue for the quarter ending 2018-09-30 was $70.04K, a 2.00% decline year-over-year.
- EDESA BIOTECH, INC. other cost of operating revenue for the quarter ending 2018-06-30 was $69.49K, a 7.39% increase year-over-year.
- EDESA BIOTECH, INC. other cost of operating revenue for fiscal 2018 was $312.00K, a 9.70% increase from fiscal 2017.
- EDESA BIOTECH, INC. other cost of operating revenue for fiscal 2017 was $284.41K, a 8.04% decline from fiscal 2016.
- EDESA BIOTECH, INC. other cost of operating revenue for fiscal 2016 was $309.26K, a 19.21% increase from fiscal 2015.
- EDESA BIOTECH, INC. other cost of operating revenue for fiscal 2015 was $259.42K, a 1.92% increase from fiscal 2014.
| Period end | Other Cost of Operating Revenue 1 month | Other Cost of Operating Revenue 3 month | Other Cost of Operating Revenue 6 month | Other Cost of Operating Revenue 9 month | Other Cost of Operating Revenue 12 month |
|---|---|---|---|---|---|
| 2019-03-31 | $35.41K 10-Q · filed 2019-05-08 | $113.69K 10-Q · filed 2019-05-08 | $183.72K derived: sum of 3 quarters · filed 2019-05-08 | $253.22K derived: sum of 4 quarters · filed 2019-05-08 | |
| 2018-12-31 | $78.28K 10-Q · filed 2019-02-05 | $148.32K derived: sum of 2 quarters · filed 2019-02-05 | $217.81K derived: sum of 3 quarters · filed 2019-02-05 | $292.23K derived: sum of 4 quarters · filed 2019-05-08 | |
| 2018-09-30 | $70.04K derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-30 | $139.53K derived: sum of 2 quarters · filed 2018-11-30 | $213.95K derived: sum of 3 quarters · filed 2019-05-08 | $312.00K 10-K · filed 2018-11-30 | |
| 2018-06-30 | $69.49K 10-Q · filed 2018-08-08 | $143.92K derived: sum of 2 quarters · filed 2019-05-08 | $241.97K 10-Q · filed 2018-08-08 | $313.43K derived: sum of 4 quarters · filed 2019-05-08 | |
| 2018-03-31 | $74.42K 10-Q · filed 2019-05-08 | $172.47K 10-Q · filed 2019-05-08 | $243.94K derived: sum of 3 quarters · filed 2019-05-08 | $308.65K derived: sum of 4 quarters · filed 2019-05-08 | |
| 2017-12-31 | $98.05K 10-Q · filed 2019-02-05 | $169.52K derived: sum of 2 quarters · filed 2019-02-05 | $234.22K derived: sum of 3 quarters · filed 2019-02-05 | $297.63K derived: sum of 4 quarters · filed 2019-02-05 | |
| 2017-09-30 | $71.47K derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-30 | $136.17K derived: sum of 2 quarters · filed 2018-11-30 | $199.58K derived: sum of 3 quarters · filed 2018-11-30 | $284.41K 10-K · filed 2018-11-30 | |
| 2017-06-30 | $64.71K 10-Q · filed 2018-08-08 | $128.11K derived: sum of 2 quarters · filed 2018-08-08 | $212.94K 10-Q · filed 2018-08-08 | $298.98K derived: sum of 4 quarters · filed 2018-08-08 | |
| 2017-03-31 | $63.40K 10-Q · filed 2018-05-07 | $148.24K 10-Q · filed 2018-05-07 | $234.27K derived: sum of 3 quarters · filed 2018-05-07 | $293.34K derived: sum of 4 quarters · filed 2018-05-07 | |
| 2016-12-31 | $84.83K 10-Q · filed 2018-02-07 | $170.87K derived: sum of 2 quarters · filed 2018-02-07 | $229.94K derived: sum of 3 quarters · filed 2018-02-07 | $309.18K derived: sum of 4 quarters · filed 2018-02-07 | |
| 2016-09-30 | $86.04K derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-01 | $145.10K derived: sum of 2 quarters · filed 2017-12-01 | $224.35K derived: sum of 3 quarters · filed 2017-12-01 | $309.26K 10-K · filed 2017-12-01 | |
| 2016-06-30 | $59.06K 10-Q · filed 2017-08-09 | $138.31K derived: sum of 2 quarters · filed 2017-08-09 | $223.22K 10-Q · filed 2017-08-09 | $281.15K derived: sum of 4 quarters · filed 2017-12-01 | |
| 2016-03-31 | $79.25K 10-Q · filed 2017-05-09 | $164.16K 10-Q · filed 2017-05-09 | $222.09K derived: sum of 3 quarters · filed 2017-12-01 | $275.53K derived: sum of 4 quarters · filed 2017-12-01 | |
| 2015-12-31 | $84.91K 10-Q · filed 2017-02-06 | $142.84K derived: sum of 2 quarters · filed 2017-12-01 | $196.28K derived: sum of 3 quarters · filed 2017-12-01 | $263.16K derived: sum of 4 quarters · filed 2017-12-01 | |
| 2015-09-30 | $57.93K derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-01 | $111.37K derived: sum of 2 quarters · filed 2017-12-01 | $178.25K derived: sum of 3 quarters · filed 2017-12-01 | $259.42K 10-K · filed 2017-12-01 | |
| 2015-06-30 | $53.44K 10-Q · filed 2016-08-09 | $120.32K derived: sum of 2 quarters · filed 2016-08-09 | $201.50K 10-Q · filed 2016-08-09 | ||
| 2015-03-31 | $66.88K 10-Q · filed 2016-05-09 | $148.06K 10-Q · filed 2016-05-09 | |||
| 2014-12-31 | $81.18K 10-Q · filed 2016-02-08 | ||||
| 2014-09-30 | $22.06K 10-K · filed 2016-12-14 | ||||
| 2014-08-31 | $254.53K 10-K · filed 2016-12-14 | ||||
| 2013-08-31 | $137.45K 10-K · filed 2015-12-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B |